Allogene Therapeutics
ALLO
ALLO
154 hedge funds and large institutions have $413M invested in Allogene Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 67 increasing their positions, 37 reducing their positions, and 29 closing their positions.
Holders
154
Holders Change
-17
Holders Change %
-9.94%
% of All Funds
2.46%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
67
Reduced
37
Closed
29
Calls
$195K
Puts
$469K
Net Calls
-$274K
Net Calls Change
-$97K
Top Buyers
1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$33.6M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$21.9M |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$5.83M |
4 |
4
BlackRock
New York
|
$28.2M |
5 |
CANY
5
Caxton Associates (New York)
New York
|
$1.52M |